MICA and renal cell carcinoma: TMP could activate NK cells through upregulating NKG2D ligands (NKG2DLs) MHC class I chain-related molecules A and B (MICA/B) expression, which could further suppress RCC epithelial-mesenchymal transition (EMT) progression (Luan et al., 2016).